Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 709893, 9 pages
http://dx.doi.org/10.1155/2012/709893
Review Article

Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor

1Translational Science and Technologies, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
2Centro de Investigación Lilly, Eli Lilly and Company, 28108 Alcobendas, Madrid, Spain
3Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA

Received 31 December 2011; Accepted 24 January 2012

Academic Editor: Matteo Monami

Copyright © 2012 Francis S. Willard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [39 citations]

The following is the list of published articles that have cited the current article.

  • Francis S. Willard, Denise Wootten, Aaron D. Showalter, Emilia E. Savage, James Ficorilli, Thomas B. Farb, Krister Bokvist, Jorge Alsina-Fernandez, Sebastian G. B. Furness, Arthur Christopoulos, Patrick M. Sexton, and Kyle W. Sloop, “Small Molecule Allosteric Modulation of the Glucagon-Like Peptide-1 Receptor Enhances the Insulinotropic Effect of Oxyntomodulin,” Molecular Pharmacology, vol. 82, no. 6, pp. 1066–1073, 2012. View at Publisher · View at Google Scholar
  • Naichang Li, Jing Lu, and Gary B. Willars, “Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor,” PLoS ONE, vol. 7, no. 10, 2012. View at Publisher · View at Google Scholar
  • Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson, and Amit S. Kalgutkar, “Demonstration of the Innate Electrophilicity of 4-(3(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor,” Drug Metabolism and Disposition, vol. 41, no. 8, pp. 1470–1479, 2013. View at Publisher · View at Google Scholar
  • Denise Wootten, Emilia E. Savage, Francis S. Willard, Ana B. Bueno, Kyle W. Sloop, Arthur Christopoulos, and Patrick M. Sexton, “Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands,” Molecular Pharmacology, vol. 83, no. 4, pp. 822–834, 2013. View at Publisher · View at Google Scholar
  • Stephen P H Alexander, Helen E Benson, Elena Faccenda, Adam J Pawson, Joanna L Sharman, Michael Spedding, John A Peters, and Anthony J Harmar, “The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.,” British journal of pharmacology, vol. 170, no. 8, pp. 1459–581, 2013. View at Publisher · View at Google Scholar
  • Elizabeth V. Denton, Cody J. Craig, Rebecca L. Pongratz, Jacob S. Appelbaum, Amy E. Doerner, Arjun Narayanan, Gerald I. Shulman, Gary W. Cline, and Alanna Schepartz, “A β-peptide agonist of the GLP-1 receptor, a class B GPCR,” Organic Letters, vol. 15, no. 20, pp. 5318–5321, 2013. View at Publisher · View at Google Scholar
  • Graham M. West, Francis S. Willard, Kyle W. Sloop, Aaron D. Showalter, Bruce D. Pascal, and Patrick R. Griffin, “Glucagon-Like Peptide-1 Receptor Ligand Interactions: Structural Cross Talk between Ligands and the Extracellular Domain,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Whitney M. Nolte, Jean-Philippe Fortin, Benjamin D. Stevens, Gary E. Aspnes, David A. Griffith, Lise R. Hoth, Roger B. Ruggeri, Alan M. Mathiowetz, Chris Limberakis, David Hepworth, and Philip A. Carpino, “A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification,” Nature Chemical Biology, vol. 10, no. 8, pp. 629–U162, 2014. View at Publisher · View at Google Scholar
  • L J Miller, P M Sexton, M Dong, and K G Harikumar, “The class B G-protein-coupled GLP-1 receptor: an important target for the treatment of type-2 diabetes mellitus.,” International journal of obesity supplements, vol. 4, no. Suppl1, 2014. View at Publisher · View at Google Scholar
  • Nian Gong, Hui Fan, Ai-Niu Ma, Qi Xiao, and Yong-Xiang Wang, “Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors,” Neuropharmacology, 2014. View at Publisher · View at Google Scholar
  • Lindsey C Morris, Ryan D Morrison, J Scott Daniels, Kevin D Niswender, Craig W Lindsley, Kellie D Nance, Patrick R Gentry, Emily L Days, C David Weaver, Colleen M Niswender, Analisa D Thompson, Carrie K Jones, and Chuck W Locuson, “Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).,” Journal of medicinal chemistry, vol. 57, no. 23, pp. 10192–7, 2014. View at Publisher · View at Google Scholar
  • Spasov, and Chepljaeva, “Potential of pharmacological modulation of level and activity of incretins in diabetes mellitus type 2,” Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, vol. 8, no. 4, pp. 293–301, 2014. View at Publisher · View at Google Scholar
  • Yunjun Ge, Dehua Yang, Antao Dai, Caihong Zhou, Yue Zhu, and Ming‑Wei Wang, “The putative signal peptide of glucagon-like peptide-1 receptor is not required for receptor synthesis but promotes receptor expression,” Bioscience Reports, vol. 34, no. 6, pp. 717–727, 2014. View at Publisher · View at Google Scholar
  • Chong-Sheng Peng, Yong-Xiang Wang, Bin Zhu, Nian Gong, Hui Fan, Xiu-Juan Ding, and Yi Jiang, “Lamiophlomis rotata, an orally available tibetan herbal painkiller, specifically reduces pain hypersensitivity states through the activation of spinal glucagon-like peptide-1 receptors,” Anesthesiology, vol. 121, no. 4, pp. 835–851, 2014. View at Publisher · View at Google Scholar
  • M.K. Unnikrishnan, Veeresh Veerapur, Yogendra Nayak, Piya Paul Mudgal, and Geetha Mathew, “Antidiabetic, Antihyperlipidemic and Antioxidant Effects of the Flavonoids,” Polyphenols in Human Health and Disease, pp. 143–161, 2014. View at Publisher · View at Google Scholar
  • Prashant Nadkarni, Oleg G. Chepurny, and George G. Holz, “Regulation of Glucose Homeostasis by GLP-1,” Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus, vol. 121, pp. 23–65, 2014. View at Publisher · View at Google Scholar
  • Hui Fan, Teng-Fei Li, Nian Gong, and Yong-Xiang Wang, “Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial β-endorphin expression,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  • Joakim E. Swedberg, Christina I. Schroeder, Justin Mitchell, Thomas Durek, David P. Fairlie, David J. Edmonds, David A. Griffith, Roger B. Ruggeri, David R. Derksen, Paula M. Loria, Spiros Liras, David A. Price, and David J. Craik, “Cyclic alpha-Conotoxin Peptidomimetic Chimeras as Potent GLP-1R Agonists,” European Journal of Medicinal Chemistry, 2015. View at Publisher · View at Google Scholar
  • Harleen Kaur, Naved Ahmad, and Ritu Chauhan, “In-silico study of computational modelling and GLP-1 receptor inverse agonist compounds on a cancer cell line inhibitory bioassay dataset,” International Journal of Computational Biology and Drug Design, vol. 8, no. 3, pp. 293–309, 2015. View at Publisher · View at Google Scholar
  • A.A. Spasov, and N.I. Chepljaeva, “Potential of pharmacological modulation of level and activity incretins on diabetes mellitus type 2,” Biomeditsinskaya Khimiya, vol. 61, no. 4, pp. 488–496, 2015. View at Publisher · View at Google Scholar
  • Li-Hua Zhao, Ming-Wei Wang, Karsten Melcher, H. Eric Xu, Bo Liu, Xiaoxi Wang, Kuntal Pal, Yi Jiang, Yang Feng, Xiaoqing Cai, Antao Dai, Mingyao Liu, Yanting Yin, Dehua Yang, and Li Hou, “Differential requirement of the extracellular domain in activation of class B G protein-coupled receptors,” Journal of Biological Chemistry, vol. 291, no. 29, pp. 15119–15130, 2016. View at Publisher · View at Google Scholar
  • Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Cynthia Stutsman, Aranzazu Marin, James Ficorilli, Over Cabrera, Francis S. Willard, and Kyle W. Sloop, “Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles,” Journal Of Biological Chemistry, vol. 291, no. 20, pp. 10700–10715, 2016. View at Publisher · View at Google Scholar
  • Aiysha Thompson, Jeffrey W. Stephens, Venkateswarlu Kanamarlapudi, and Stephen C. Bain, “Molecular characterisation of small molecule agonists effect on the human glucagon like peptide-1 receptor internalisation,” PLoS ONE, vol. 11, no. 4, 2016. View at Publisher · View at Google Scholar
  • Denise Wootten, Laurence J. Miller, Cassandra Koole, Arthur Christopoulos, and Patrick M. Sexton, “Allostery and Biased Agonism at Class B G Protein-Coupled Receptors,” Chemical Reviews, 2016. View at Publisher · View at Google Scholar
  • Maoqing Dong, Polo C. -H. Lam, Andrew Orry, Patrick M. Sexton, Arthur Christopoulos, Ruben Abagyan, and Laurence J. Miller, “Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues wi,” Journal Of Biological Chemistry, vol. 291, no. 10, pp. 5172–5184, 2016. View at Publisher · View at Google Scholar
  • Frank Reimann, and Fiona M. Gribble, “G protein-coupled receptors as new therapeutic targets for type 2 diabetes,” Diabetologia, vol. 59, no. 2, pp. 229–233, 2016. View at Publisher · View at Google Scholar
  • Fabien Plisson, Timothy A. Hill, Justin M. Mitchell, Huy N. Hoang, Aline D. de Araujo, Weijun Xu, Adam Cotterell, David J. Edmonds, Robert V. Stanton, David R. Derksen, Paula M. Loria, David A. Griffith, David A. Price, Spiros Liras, and David P. Fairlie, “Helix-constraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling,” European Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Chris de Graaf, Caihong Zhou, Ming-Wei Wang, Dan Donnelly, Denise Wootten, Jesper Lau, Patrick M. Sexton, Jiayu Liao, Madeleine M. Fletcher, Dehua Yang, Alastair J. H. Brown, Jiejie Deng, Laurence J. Miller, and Jung-Mo Ahn, “Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long march to therapeutic successes,” Pharmacological Reviews, vol. 68, no. 4, pp. 954–1013, 2016. View at Publisher · View at Google Scholar
  • Clifford J Bailey, Abd A Tahrani, and Anthony H Barnett, “Future glucose-lowering drugs for type 2 diabetes,” The Lancet Diabetes & Endocrinology, 2016. View at Publisher · View at Google Scholar
  • I-Wen Chou, Yu-Hong Cheng, Yet-Ran Chen, Patrick Ching-Ho Hsieh, and Klim King, “Fenugreek Compound (N55) Lowers Plasma Glucose through the Enhancement of Response of Physiological Glucagon-like peptide-1,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Fan Wu, Gaojie Song, Chris de Graaf, and Raymond C. Stevens, “Structure and function of peptide-binding G protein-coupled receptors,” Journal of Molecular Biology, 2017. View at Publisher · View at Google Scholar
  • Ali Jazayeri, Asma H. Baig, Fiona H. Marshall, James Kean, Cédric Fiez-Vandal, Andrea Bortolato, Jonathan S. Mason, Iryna Teobald, Andrew S. Doré, Malcolm Weir, Robert M. Cooke, Mathieu Rappas, Alastair J. H. Brown, James C. Errey, Nathan J. Robertson, Stephen P. Andrews, and Miles Congreve, “Crystal structure of the GLP-1 receptor bound to a peptide agonist,” Nature, vol. 546, no. 7657, pp. 254–258, 2017. View at Publisher · View at Google Scholar
  • Kellie D. Nance, Emily L. Days, C. David Weaver, Anastasia Coldren, Tiffany D. Farmer, Hyekyung P. Cho, Colleen M. Niswender, Anna L. Blobaum, Kevin D. Niswender, and Craig W. Lindsley, “ Discovery of a Novel Series of Orally Bioavailable and CNS Penetrant Glucagon-like Peptide-1 Receptor (GLP-1R) Noncompetitive Antagonists Based on a 1,3-Disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5- d ]pyrimidine-2,4(1 H ,3 H )-dione Core ,” Journal of Medicinal Chemistry, 2017. View at Publisher · View at Google Scholar
  • Jacob D. Brown, Elnaz Karimian Azari, and Julio E. Ayala, “Oleoylethanolamide: A fat ally in the fight against obesity,” Physiology & Behavior, 2017. View at Publisher · View at Google Scholar
  • Meng Xu, Hai-Yun Wu, Hao Liu, Nian Gong, Yi-Rui Wang, and Yong-Xiang Wang, “ Morroniside, a secoiridoid glycoside from Cornus officinalis , attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors ,” British Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Jacob D. Brown, Danielle McAnally, Jennifer E. Ayala, Melissa A. Burmeister, Camilo Morfa, Layton Smith, and Julio E. Ayala, “Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 315, no. 4, pp. R595–R608, 2018. View at Publisher · View at Google Scholar
  • Philippe Delerive, Roger J. Summers, Patrick M. Sexton, Darren M. Riddy, and Christopher J. Langmead, “G protein–coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus,” Pharmacological Reviews, vol. 70, no. 1, pp. 39–67, 2018. View at Publisher · View at Google Scholar
  • Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, and Hui-Kang Liu, “Effects of Boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1.,” Phytomedicine, pp. 152946, 2019. View at Publisher · View at Google Scholar
  • Tejashree Redij, Rajan Chaudhari, Zhiyu Li, Xianxin Hua, and Zhijun Li, “Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor,” ACS Omega, vol. 4, no. 1, pp. 961–970, 2019. View at Publisher · View at Google Scholar